Marathon Venture Capital

Marathon Venture Capital is an early-stage venture capital firm based in Athens, Greece, that concentrates on seed-stage technology investments across the country. Founded in 2017, the firm seeks to support ambitious Greek founders who aim to build world-class technology companies, often collaborating with like-minded entrepreneurs to develop ventures from the ground up. Its portfolio includes notable companies such as Bugsense, Taxibeat, Workable, and Resin.io, reflecting a track record of backing technology teams that pursue large-scale impact.

Alex Alexakis

Analyst

Thaleia Misailidou

Principal

Panos Papadopoulos

Partner

George Tziralis

Partner

Past deals in Greece

Causaly

Series B in 2023
Causaly Inc., founded in 2017, is a company based in Wilmington, Delaware, with additional offices in London and Athens. It specializes in developing artificial intelligence solutions for biomedical cause and effect discovery. Causaly's platform uses semantic AI to read scientific articles, extracting causal associations through linguistic and statistical models. This technology validates causal claims, generates hypotheses, and provides tools for semantic search, causal analytics, and hypothesis simulation. The company's services are tailored to the research industry, aiming to amplify human cognitive abilities and accelerate biomedical discoveries by uncovering hidden evidence and making new predictions in biomedicine.

Causaly

Series A in 2021
Causaly Inc., founded in 2017, is a company based in Wilmington, Delaware, with additional offices in London and Athens. It specializes in developing artificial intelligence solutions for biomedical cause and effect discovery. Causaly's platform uses semantic AI to read scientific articles, extracting causal associations through linguistic and statistical models. This technology validates causal claims, generates hypotheses, and provides tools for semantic search, causal analytics, and hypothesis simulation. The company's services are tailored to the research industry, aiming to amplify human cognitive abilities and accelerate biomedical discoveries by uncovering hidden evidence and making new predictions in biomedicine.

Causaly

Series A in 2019
Causaly Inc., founded in 2017, is a company based in Wilmington, Delaware, with additional offices in London and Athens. It specializes in developing artificial intelligence solutions for biomedical cause and effect discovery. Causaly's platform uses semantic AI to read scientific articles, extracting causal associations through linguistic and statistical models. This technology validates causal claims, generates hypotheses, and provides tools for semantic search, causal analytics, and hypothesis simulation. The company's services are tailored to the research industry, aiming to amplify human cognitive abilities and accelerate biomedical discoveries by uncovering hidden evidence and making new predictions in biomedicine.

Causaly

Seed Round in 2018
Causaly Inc., founded in 2017, is a company based in Wilmington, Delaware, with additional offices in London and Athens. It specializes in developing artificial intelligence solutions for biomedical cause and effect discovery. Causaly's platform uses semantic AI to read scientific articles, extracting causal associations through linguistic and statistical models. This technology validates causal claims, generates hypotheses, and provides tools for semantic search, causal analytics, and hypothesis simulation. The company's services are tailored to the research industry, aiming to amplify human cognitive abilities and accelerate biomedical discoveries by uncovering hidden evidence and making new predictions in biomedicine.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.